当前位置:首页 - 行情中心 - 迈威生物-U(688062) - 财务分析

迈威生物-U

(688062)

  

流通市值:31.87亿  总市值:62.38亿
流通股本:2.04亿   总股本:4.00亿

迈威生物-U(688062)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-6.96亿元,每股收益-1.74元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益190497.10万元,未分配利润-444543.98万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产449758.88万元,负债259261.77万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入141,095,928.06115,528,061.7267,555,138.51127,835,534.42
营业总成本844,467,620.3566,927,225.5282,657,001.661,175,894,797.97
营业利润-692,034,701.16-443,304,727.01-206,210,659.08-1,052,579,065.57
利润总额-694,111,078.54-444,340,939.36-206,210,666.06-1,055,287,603.71
净利润-696,015,164.94-446,245,025.76-206,210,666.06-1,058,811,365.59
其他综合收益-1,015,688.86568,007.37123,084.63,244,278.37
综合收益总额-697,030,853.8-445,677,018.39-206,087,581.46-1,055,567,087.22
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计2,017,126,099.032,098,846,512.712,217,103,319.762,047,592,313.46
非流动资产合计2,480,462,658.112,462,535,789.382,424,711,971.392,407,456,127.25
资产总计4,497,588,757.144,561,382,302.094,641,815,291.154,455,048,440.71
流动负债合计1,443,085,654.891,178,770,913.871,051,476,382.89816,386,767.78
非流动负债合计1,149,532,0931,226,370,691.491,194,635,453.111,065,413,609.68
负债合计2,592,617,747.892,405,141,605.362,246,111,8361,881,800,377.46
归属于母公司股东权益合计1,917,349,658.512,167,957,308.12,406,709,424.562,583,701,890.99
股东权益合计1,904,971,009.252,156,240,696.732,395,703,455.152,573,248,063.25
负债和股东权益合计4,497,588,757.144,561,382,302.094,641,815,291.154,455,048,440.71
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计299,141,739.35211,078,367.6390,544,176.33292,707,770.69
经营活动现金流出小计967,362,530.41672,702,139.11421,141,114.361,075,436,050.03
经营活动产生的现金流量净额-668,220,791.06-461,623,771.48-330,596,938.03-782,728,279.34
投资活动现金流入小计322,059,417.02248,477,221.64107,716,644.21496,718,038.74
投资活动现金流出小计525,231,877.39390,367,359.05283,505,565.221,006,340,829.04
投资活动产生的现金流量净额-203,172,460.37-141,890,137.41-175,788,921.01-509,622,790.3
筹资活动现金流入小计2,242,633,290.692,068,833,290.691,360,160,000612,096,391.06
筹资活动现金流出小计1,415,498,893.271,372,180,492.27775,719,243.89167,160,272.85
筹资活动产生的现金流量净额827,134,397.42696,652,798.42584,440,756.11444,936,118.21
汇率变动对现金及现金等价物的影响-933,514.53225,233.9913,974.421,403,497.51
现金及现金等价物净增加额-45,192,368.5493,364,123.5278,068,871.49-846,011,453.92
期末现金及现金等价物余额1,598,440,866.221,736,997,358.281,721,702,106.251,643,633,234.76
最新报告期:2024-11-04
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
国联证券郑薇-2.10-1.60-0.502024-11-04
TOP↑